UPDATE 1-FDA to review re-submitted Bristol-Myers hepatitis C drug
March 12, 2015 at 16:34 PM EDT
March 12 (Reuters) - U.S. regulators have accepted Bristol-Myers Squibb Co's re-submitted marketing application for an experimental hepatitis C treatment after the drugmaker was forced last year to withdraw its initial request.